Enzon Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced total revenue was USD 207,000 compared to USD 6.918 million a year ago. Operating loss was USD 973,000 compared to operating Income of USD 5.855 million a year ago. Net loss was USD 979,000 compared to net income of USD 5.849 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.13 a year ago.